ERBB2 and triple-negative breast carcinoma: Triple-negative breast cancer (TNBC) is defined by the lack of expression of the estrogen receptor (ER), the progesterone receptor (PR) and the absence of human epidermal growth factor receptor 2 (HER2) overexpression and/or gene amplification.